Strategic Roadmap and Financial Performance
Financial Highlights | Strong Underlying Growth
Total Income(1) (2) (4)
1Q-2022
AED 46.9 MN
vs AED 42.0 MN in 1Q-21 (+12%)
Total Income | AED MN
Net Profit (1)
1Q-2022
AED 32.0 MN
vs AED 31.5 MN in 1Q-21 (+2%)
Net Profit | AED MN
Adjusted Net Profit (1) (3)
1Q-2022
AED 32.1 MN
vs AED 23.1 MN in 1Q-21 (+39%)
Adjusted Net Profit | AED MN
371.0
112
60.0
74.2
42.0
46.9
20.3
10.1
280.8
26.0
32.0
14.6
31.5
5.7
103.4
3.1
32.1
23.1
FY19
FY20
FY21
1Q20 1Q21
1Q22
FY19
FY20
FY21
1Q20 1Q21
1Q22
FY19
FY20
FY21 1Q20
1Q21
1Q22
(1) Excluding NCI (2) Includes share of net income from subsidiaries (Middlesex University Dubai, Royal Hospital for Women & Children and CMRC), Finance Lease income generated from the real estate
assets of North London Collegiate School Dubai and result from associates (Sukoon and NEMA Holding), net of PPA. The prior year also includes share of results from divested associates (Taaleem and
International Medical Center). (3) Excludes the trading performance of Taaleem and International Medical Center in the prior year and transaction costs in the current and prior year. Refer to other financial
information for a detailed reconciliation. (4) Finance charges in relation to the Royal Hospital for Women & Children have been reclassified from platform income to finance charges in the current period. The
prior period has been restated accordingly. (*) Due to rounding, numbers presented may not add up precisely to the totals provided and the percentages may not precisely reflect the absolute percentages
9View entire presentation